Quan C P, Watanabe S, Vuillier F, Pires R, Matsuo T, Stanislawski M, Pillot J, Bouvet J P
Institut Pasteur Paris Unité d'Immunologie Microbienne, France.
Immunology. 1993 Feb;78(2):205-9.
A T-suppressor (TS) lymphokine was purified from the supernatant of a T hybridoma established from CD3+ CD8+ CD57+ lymphocytes of a healthy bone marrow transplant patient. Using polyclonal rabbit antibodies, raised against a TS-enriched preparation, a specific protein of 47,000 MW was identified, which was used to prepare monoclonal antibodies. The screening of hybridomas was carried out by strip-ELISA, in which the 47,000 MW band, transferred on a membrane, served as antigen. One of these monoclonal antibodies (IgM kappa) was selected for purification of the native TS molecule, which exhibited the high suppressive activity on the phytohaemagglutinin (PHA) and alloantigen responses of peripheral blood lymphocytes. The establishment of amino acid sequences of five trypsinized cleavage peptides confirmed that this protein has not been previously identified. This lymphokine--also detected in the supernatant of normal CD8+ CD57+ lymphocytes--is likely involved in bone marrow transplantation tolerance.
从一名健康骨髓移植患者的CD3+ CD8+ CD57+淋巴细胞建立的T杂交瘤上清液中纯化出一种抑制性T细胞(TS)淋巴因子。使用针对富含TS的制剂产生的多克隆兔抗体,鉴定出一种分子量为47,000的特异性蛋白质,并用其制备单克隆抗体。杂交瘤的筛选通过条带ELISA进行,其中转移到膜上的47,000分子量条带用作抗原。选择其中一种单克隆抗体(IgM κ)来纯化天然TS分子,该分子对外周血淋巴细胞的植物血凝素(PHA)和同种异体抗原反应表现出高抑制活性。五个胰蛋白酶消化裂解肽的氨基酸序列的确定证实该蛋白质以前未被鉴定过。这种淋巴因子——在正常CD8+ CD57+淋巴细胞的上清液中也能检测到——可能参与骨髓移植耐受性。